Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.
about
'Blood doping' from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patientsPerformance Enhancement: What Are the Physiological Limits?Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefitThe ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia.Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid systemSkeletal muscle alterations and exercise performance decrease in erythropoietin-deficient mice: a comparative studyDoping in sport: effects, harm and misconceptions.Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.Convective oxygen transport and fatigue.Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.Heart Rate Variability Correlates to Functional Aerobic Impairment in Hemodialysis Patients.The evolving science of detection of 'blood doping'.Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate StatisticsNovel serum biomarkers for erythropoietin use in humans: a proteomic approach.Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome.Effects of recombinant human erythropoietin in normal humans.Red blood cell volume and the capacity for exercise at moderate to high altitude.Blood doping: potential of blood and urine sampling to detect autologous transfusion.Maximal oxygen consumption in healthy humans: theories and facts.Erythropoietin treatment enhances muscle mitochondrial capacity in humans.Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.Satellite cell response to erythropoietin treatment and endurance training in healthy young men.Hyperoxia for performance and training.Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.Effects of erythropoietin abuse on exercise performance.RhEPO improves time to exhaustion by non-hematopoietic factors in humans.Detection of erythropoietin misuse by the Athlete Biological Passport combined with reticulocyte percentage.Dietary nitrate supplementation attenuates the reduction in exercise tolerance following blood donation.Effects of an 8-weeks erythropoietin treatment on mitochondrial and whole body fat oxidation capacity during exercise in healthy males.Current markers of the Athlete Blood Passport do not flag microdose EPO doping.Erythropoietin does not reduce plasma lactate, H⁺, and K⁺ during intense exercise.
P2860
Q26765195-2735A6AA-DB10-4A8F-A744-9085E2B29B9CQ26866551-DD0F0AE9-3FE4-46DD-A32A-48D6FC23D8D1Q26999850-2A7EEDB3-DE3A-47AC-B124-26D8D000B445Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8Q34100489-99757E96-1747-49FE-A0F0-52FBE5336DFDQ34322475-AF237C64-509A-41A8-9E3E-300BD0CCE643Q34446275-AEDF417A-42C7-4772-AB53-288064142552Q34589872-F5C8F6C4-B3EB-4B04-99FB-8F3E0F382C70Q34707027-1CB99355-7DAC-4BDA-A942-5EB1B3675295Q35356050-CC0236B5-0A39-4006-A39A-3A7DEAF957E2Q35794582-E02406AD-7B4C-466C-9A93-8F885C94EB2EQ36024838-84078309-908D-4717-A2B4-8F005DC32280Q36048055-64AD949E-9B17-40DD-A2B4-2DFDEA4FF45BQ37202283-35FDD4A6-CF96-4E5A-8218-8793EF8F1923Q37418618-B9024705-0D57-43C3-8DD8-CDA887B12E0CQ37784333-00ADEAB5-6A7F-4A77-9B71-6B22EC05745DQ38022266-930C109E-5882-4254-8C64-3262722259DCQ38207008-C3DF3C16-5044-413E-B9E5-C03505458CE7Q38225478-5322A76B-9F1F-4D25-8E99-F889F0C1C0D5Q42587694-D5422904-99E9-4330-B11C-102C0E81742BQ44653851-21053E1D-711A-44C1-B31C-24F423123177Q47615807-39CB0E07-4B41-402E-9466-672C35D24B32Q47718984-77A90E60-F5CC-4A83-97B0-B4EDF87BD875Q47967042-C5084478-75EB-4FBB-B72A-BF49015054F2Q48347751-1815396A-B9D8-448E-A2CF-F0D08C924F2CQ50273353-2F2C856E-104F-48B6-8A04-E63905BBEAA6Q51437561-2F74AF7B-476A-480B-82DF-22B79772074EQ51440791-50DC4EA5-C7A1-42AC-B73D-D128E37DF2C1Q51695128-C8F38429-B7EE-4D9F-B8B0-B00B332C681BQ53115109-6F733E2C-FA76-47D4-B85C-8BBEDF94CA91Q53653723-C23F3781-2F14-4527-8272-72F7BC6C2BDC
P2860
Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prolonged administration of re ...... than maximal aerobic capacity.
@en
Prolonged administration of re ...... than maximal aerobic capacity.
@nl
type
label
Prolonged administration of re ...... than maximal aerobic capacity.
@en
Prolonged administration of re ...... than maximal aerobic capacity.
@nl
prefLabel
Prolonged administration of re ...... than maximal aerobic capacity.
@en
Prolonged administration of re ...... than maximal aerobic capacity.
@nl
P2093
P1476
Prolonged administration of re ...... than maximal aerobic capacity.
@en
P2093
P2888
P304
P356
10.1007/S00421-007-0522-8
P577
2007-08-01T00:00:00Z